… A total of 24 patients with cryptococcal meningitis secondary to AIDS … cryptococcal meningitis
occurs in most instances in long-standing HIV and cases of noncompliance with therapeutic …

… The incidence of cryptococcal meningitis (CM) in the developed world has declined with
widespread, early antiretroviral therapy (ART), but cryptococcal disease remains a major …

… the clinical characteristics and therapeutic outcomes of non-HIV… Cryptococcal meningitis
(CM) is one of the most common … occurs in patients with human immunodeficiency virus (HIV) …

… the combination of amphotericin-B deoxycholate (0.7 mg/kg/day) and flucytosine (100 mg/kg/day)
as a standard of care for the treatment of cryptococcal meningitis in AIDS patients. A …

… disease or may present with cryptococcal meningitis as AIDS defining illness. High degree
of clinical suspicion and timely induction of treatment is associated with better outcomes. …

… meningitis is the most common neurological manifestation in HIV patients, followed by
cryptococcus meningitis. … has reduced OIs incidence but initiation and maintenance of therapy are …

… The most frequent clinical sign at the start of treatment in our cohort was headache, and …
clinical profile of NeuroMeningeal Cryptococcosis (NMC) in People Living with HIV (PLHIV) in …

… therapies specific to patient and clinical characteristics, … profiles predict risk of early mortality
and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis…

… the clinical, biological, and therapeutic characteristics, antifungal susceptibility profile of …
Cryptococcal meningitis has been described as an opportunistic infection in HIVIP, mainly …

… cryptococcal meningitis (CM). We describe the incidence, clinical presentation, and outcome
of CM in HIV-… A description of neurological symptoms of CM at presentation and follow-up in …